Economic Features of Antibiotic Resistance: The Case of Methicillin-Resistant Staphylococcus aureus Fernando AntonanzasCarmen LozanoCarmen Torres Leading Article 02 December 2014 Pages: 285 - 325
Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis Wei ZhangNazrul IslamAslam H. Anis Systematic Review 05 December 2014 Pages: 327 - 340
Cost-of-Illness Studies for Bipolar Disorder: Systematic Review of International Studies Huajie JinPaul McCrone Systematic Review 10 January 2015 Pages: 341 - 353
An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis Rachael Maree HunterGianluca BaioNick Freemantle Practical Application 17 January 2015 Pages: 355 - 366
Cost Effectiveness of Dabrafenib as a First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in Canada Thomas E. DeleaJordan AmdahlMarroon Thabane Original Research Article 09 December 2014 Pages: 367 - 380
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX®) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective Rizwan HamidClara LovemanDmitry Gultyaev Original Research Article Open access 20 December 2014 Pages: 381 - 393
Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control Andrej JanzicMitja Kos Original Research Article 16 December 2014 Pages: 395 - 408
Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy Essè Ifèbi Hervé AkpoKarin CerriJoris Kleintjens Original Research Article Open access 11 January 2015 Pages: 409 - 422